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ABSTRACT	KELSEY	PETTUS:	Study	of	An	Active-State	CB1	Receptor	Model	and	JWH	Compound	Interactions	to	Predict	New	Emerging	Synthetic	Cannabinoids		(Under	the	direction	of	Dr.	Murrell	Godfrey	and	Dr.	Robert	J.	Doerksen)		 		 In	recent	years,	a	new	class	of	compounds,	called	synthetic	cannabinoids,	have	made	their	appearance	in	the	market	as	a	substitute	for	illegal	marijuana	or	its	constituent	natural	cannabinoids.	These	compounds,	which	are	active	at	the	same	G-protein	coupled	receptors	(GPCRS)	as	cannabinoids,	are	continuing	to	gain	popularity	because	of	the	same	cannabinoid-like	effects	they	create.	Though	two	cannabinoid	receptors	have	been	identified	in	humans,	known	as	CB1	and	CB2,	synthetic	cannabinoid	activity	at	the	CB1	receptor	has	been	the	focus	of	much	research	regarding	synthetic	cannabinoid	ligand	binding.	In	this	study,	the	structure	of	the	CB1	receptor	is	further	analyzed	in	the	binding	of	a	class	of	synthetic	cannabinoid	ligands,	known	as	JWH	compounds,	to	the	CB1	receptor.	An	active-state	CB1	model	that	was	previously	created	by	Doerksen	R.	et	al.	and	modeled	from	Bovine	Rhodopsin	and	other	GPCRs	is	used	in	this	study.	A	dataset	of	twenty-one	active	CB1	agonists	JWH	compounds	from	the	naphthoylindole	family	were	docked	to	the	model	in	order	to	further	analyze	key	interacting	residues	on	the	CB1	receptor.	Of	these	twenty-one	compounds,	all	twenty-one	were	able	to	bind	to	the	
		 v	
CB1	active-state	model.	The	Glide	docking	score	of	each	ligand	generated	from	Maestro	computational	modeling	software	was	collected	and	compared	to	that	of	Delta-9-tetrahydrocannabinol,	the	main	psychoactive	component	of	marijuana.																			
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INTRODUCTION			 In	the	United	States,	marijuana	is	ranked	as	the	second	most	pervasive	recreational	drug.	The	first	most	pervasive	recreational	drug	in	the	United	States	is	alcohol.	Though	the	possession,	use,	and	distribution	of	marijuana	are	still	under	federal	control,	the	legal	status	and	usage	patterns	of	this	drug	are	changing	rapidly.	Currently,	twenty-three	states	and	the	District	of	Columbia	have	passed	laws	that	permit	and	regulate	the	usage	of	marijuana	for	medicinal	purposes,	and	four	states	plus	the	District	of	Columbia	have	passed	laws	that	allow	for	marijuana	to	be	used	for	recreational	and	medical	purposes.1				 Because	the	possession,	distribution,	and	use	of	marijuana	continue	to	be	considered	offenses	in	federal	jurisdictions,	drug	distributers	have	been	motivated	to	create	diverse	classes	of	synthetic	analogs	as	a	legal	alternative	to	traditional	marijuana.	These	various	compounds	are	marketed	to	the	public	for	recreational	usage	and	have	been	found	to	possess	the	same	cannabinoid-like	effects	as	marijuana	such	as	euphoria,	relaxation,	increase	in	sensory	awareness,	and	increase	in	creative	thinking.1	Until	2012,	manufacturers	sold	these	synthetic	cannabinoid	
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mixtures,	also	called	"new	psychoactive	substances",	in	gas	stations,	through	the	Internet,	and	drug	paraphernalia	stores.	They	were	sold	in	the	form	of	shredded	plant	material	coated	in	cannabinoid	spray	liquid	to	be	smoked	as	herbal	incense	or	liquids	to	be	vaporized	as	liquid	incense	and	marked	"not	for	human	consumption".	
8,9	In	recent	years,	these	compounds	have	gained	much	attention	from	the	forensic	community	because	of	their	adverse	consequences	on	human	health.1	Many	of	these	synthetic	compounds	have	been	found	to	be	100	times	more	potent	than	the	main	psychoactive	component	found	in	marijuana,	Δ9-Tetrahydrocannabinol	(THC),	and	can	cause	life-threatening	problems	such	as	high	blood	pressure,	vomiting,	and	seizures.2			 		 The	specific	classes	of	compounds	that	have	gained	much	attention	from	researchers	include	those	compounds	of	the	following	series:	HU,	CP,	JWH,	AM,	RCS,	WIN,	and	in	recent	years,	UR	and	XLR2.	These	compounds	mimic	the	effects	caused	by	THC,	which	was	discovered	in	1964	by	researchers	Yechiel	Gaoni	and	Raphael	Mechoulam.	Because	the	components	of	cannabis	had	been	studied,	but	no	structure	of	the	major	psychoactive	component	had	been	determined,	the	discovery	of	the	structure	of	THC	was	a	momentous	breakthrough	for	the	scientific	community.2	The	classification	of	the	structure	of	THC	led	to	new	insights	into	the	study	of	cannabinoids.	The	structure	of	THC	is	shown	in	Figure	1.	
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Figure	1:	Structure	of	Δ9	-	Tetrahydrocannabinol	(THC)			 Because	synthetic	cannabinoids	are	functionally	similar	to	THC,	they	bind	to	the	same	cannabinoid	receptors	in	the	peripheral	organs	and	the	brain.3	Researchers	have	identified	two	known	types	of	cannabinoid	receptors	that	are	G-coupled	protein	receptors	(GPCRs).	These	receptors	are	known	as	CB1,	located	primarily	in	the	human	brain,	and	CB2,	located	primarily	in	the	immune	system	and	peripheral	organs.3	The	existence	of	cannabinoid	receptors	was	first	discovered	in	rat	brain	in	1988	in	which	the	experimental	data	described	a	G-protein	coupled	receptor	in	the	rat	brain	that	bound	natural	cannabinoids.2	Shortly	after	the	discovery	of	the	cannabinoid	receptors	in	rat	brain,	researchers	were	able	to	map	the	distribution	of	cannabinoid	receptors	in	human	peripheral	organs	(CB2)	and	brain	(CB1).1	Though	the	binding	affinities	of	compounds	for	both	CB1	and	CB2	have	been	studied	in	the	past,	a	rise	in	studies	on	the	binding	affinities	of	compounds	
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with	the	CB1	receptor	has	increased	with	the	rising	popularity	of	synthetic	cannabinoids.1	Research	shows	that	it	is	the	CB1	receptor	that	is	responsible	for	the	psychotropic	effects	caused	by	cannabis.	Because	of	this,	a	ligand's	ability	to	bind	to	the	CB1	receptor	and	act	as	an	agonist	could	indicate	its	potential	to	be	a	recreational	use	substitute	for	marijuana.1				 		 Though	the	precise	three-dimensional	structure	of	the	CB1	receptor	is	unknown,	it	is	known	that	the	CB1	and	CB2	receptors	are	G-protein	coupled	receptors	(GPCRs),	and	they	are	embedded	within	the	cell	membrane.	As	a	GPCR,	the	CB1	receptor	contains	seven-helical	transmembrane	domains	connected	by	three	extracellular	and	three	intracellular	loops.	7,11	Ligands	are	the	molecules	that	bind	to	the	GPCRs,	control	their	activity,	and	modify	their	biological	functions.	When	an	agonist	ligand	binds	to	the	CB1	receptor,	a	conformational	change	causes	the	receptor	to	interact	with	G-proteins	contained	within	the	cell.10	Because	of	these	conformational	movements	and	corresponding	G-protein	interactions,	knowledge	about	novel	ligand	binding	to	the	CB1	receptor	could	be	beneficial.6	Using	the	Bovine	Rhodopsin	X-ray	crystal	structure	as	a	template,	several	CB1	model	structures	have	been	reported.	These	model	structures	have	further	been	used	to	discover	novel	CB1	ligands,	but	none	of	these	models	provide	for	the	precise	three-dimensional	structure	of	the	CB1	receptor	and	cannabinoid	ligand	binding.4,	Studies	have	proposed	that	there	is	a	hydrophobic	binding	pocket	that	interacts	with	the	C3	alkyl	chain	of	cannabinoids.	Since	the	precise	experimental	structure	of	the	CB1	receptor	has	yet	to	be	reported,	the	chosen	best	active-state	CB1	receptor	model	
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utilized	in	this	study	was	a	model	proposed	by	Doerksen	et	al.5	The	active-state	CB1	model	used	in	this	study	in	shown	in	Figure	2:		
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2:	The	model	of	the	CB1	receptor	used	in	this	study	with	bound	THC	
ligand	shown	in	green.			 In	1984	while	researching	and	developing	cannabinoid	compounds	to	aid	in	multiple	sclerosis	and	chemotherapy	research,	John	W.	Huffman	and	a	team	of	researchers	developed	a	group	of	synthetic	cannabinoid	ligands	that	are	today	arguably	the	most	popular	synthetic	cannabinoids.	These	compounds,	called	the	JWH	series	compounds,	were	evolved	from	the	computational	combination	of	
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aminoalkylindoles	and	features	of	THC.	The	JWH	compounds	used	in	this	study	come	from	the	naphthoylindole	class	of	synthetic	cannabinoids,	named	for	the	naphthalene	group	they	contain.	Naphthalene's	structure	is	made	of	two-fused	benzene	rings.12					 In	this	study,	the	receptor-ligand	interactions	of	an	active-state	model	of	the	human	CB1	receptor,	proposed	by	Doerksen	R.	et	al.,	and	twenty-one	JWH	cannabinoid	ligands	from	the	naphthoylindole	family	and	the	THC	molecule	are	compared.5	The	Maestro	molecular	modeling	computer	program	was	used	to	study	the	usefulness	of	the	CB1	model	and	to	investigate	the	important	interactions	between	each	ligand	and	CB1	residues.13	The	information	found	in	this	study	can	be	useful	in	discovering	a	more	accurate	CB1	model	and	in	predicting	the	properties	of	uncharacterized	illicit	synthetic	cannabinoids	before	they	become	products	that	are	illegally	sold	to	the	public.		 	
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EXPERIMENTAL	MATERIALS	AND	METHODS		
	
Ligands	Selection.	
	A	dataset	of	twenty-one	JWH	ligands	from	the	naphthoylindole	family	plus	the	THC	molecule	were	chosen.	All	of	these	ligands	have	an	affinity	for	the	CB1	receptor.		The	molecular	structures	of	the	twenty-one	ligands	are	listed	below	in	Figure	3	in	order	of	highest	to	lowest	docking	score.	THC	is	shown	at	the	end.		
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Figure	3:	Structures	of	the	twenty-one	JWH	ligands	and	THC	used	in	this	study	
	
Ligands	Preparation		The	ligands	selected	for	this	study	were	prepared	using	Maestro	modeling	software	created	by	Schrödinger,	LLC.13	The	twenty-one	ligands	were	entered	into	Maestro	using	the	2D	sketcher	and	then	converted	to	3D	structures	for	docking.	Using	the	preparation	wizard,	the	ligands	were	desalted	and	tautomers	were	generated	using	OPLS3	force	field.	A	target	PH	of	7.0	+/-	2.0	was	set	and	one	low	energy	ring	conformation	per	ligand	was	generated.			
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Protein	Selection	and	Preparation	The	model	selected	for	this	study	was	a	CB1	model	created	and	prepared	by	Doerksen	R.	et	al.	This	model	was	chosen	as	the	best	model	for	experimentation	because	it	showed	the	best	overall	performance	among	the	created	models.5	Doerksen	R	et	al.	previously	prepared	the	protein	used	in	this	study.	The	protein	preparation	wizard	in	Maestro	was	used	to	correct	any	problems	related	to	steric	hindrances,	distance,	and	hydrogen	atoms.	After	no	problems	were	detected	post	review,	the	orientation	of	the	protein	was	optimized	using	OPLS3	force	field.				
	
Grid	Generation	Two	grids	were	generated	to	tell	the	Maestro	program	where	to	look	on	the	CB1	protein	when	docking.	The	grids	were	generated	using	information	about	the	CB1	receptor-ligand	binding	found	in	previous	studies.	The	first	grid	was	generated	with	a	hydrogen	bond	constraint	on	residue	Lys	192.	Residues	Ser	173,	Tyr	275,	Cys	355,	Ser	383	were	chosen	as	rotatable	groups.	Previous	studies	have	shown	that	these	four	residues	selected	as	rotatable	groups	are	important	interacting	residues	for	the	CB1	receptor	in	its	active	state.	A	second	grid	was	also	generated	with	no	hydrogen	bond	constraints	and	no	residues	selected	as	rotatable	groups.			 	
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Glide	Docking		The	standard	precision	(SP)	module	in	Glide	was	used	to	dock	the	twenty-one	ligands	created.	The	Doerksen	R.	group	had	already	prepared	and	validated	the	CB1-THC	complex,	and	I	utilized	this	complex	for	generating	the	grids	considering	THC	as	an	active	ligand	site.	Post-docking	minimization	was	performed,	and	the	top	pose	of	each	ligand	was	selected	for	study.	Once	all	of	the	ligands	had	been	docked,	the	docking	score	of	each	ligand	was	reviewed	in	order	to	determine	which	ligands	had	the	better	affinity	for	the	CB1	receptor.	The	binding	site	was	also	studied	to	see	which	residues	of	the	CB1	protein	receptor	and	what	parts	of	the	ligand,	the	indole	or	naphthalene	substructures,	were	interacting.	The	shortest	distance	(in	Angstroms)	between	either	the	indole	substructure	or	the	naphthalene	substructure	of	each	ligand	and	the	interacting	residues	was	measured.								
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RESULTS	AND	DISCUSSION	
	 		 Once	the	ligand	and	protein	preparation	and	grid	generation	had	been	completed,	the	twenty-one	JWH	ligands	and	the	THC	molecule	were	docked	to	the	CB1	model.	The	docking	results	showed	that	all	twenty-one	ligands	and	the	THC	molecule	were	successfully	docked	into	the	CB1	model.	The	most	favorable	pose	for	each	ligand	and	the	THC	molecule	were	chosen	and	analyzed.	The	docking	scores	varied	from	-7.198	to	-9.334.	The	docking	scores	of	the	JWH	ligands	and	the	THC	molecule	are	listed	in	Table	1.										
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Ligands	
Docking	
Score		
Glide	
Emodel	 Ki	
JWH-149	 -9.334	 -64.999	
5.0nM	±2.1	
nM	
JWH-184	 -9.268	 -67.039	 23	nM	
JWH-164	 -9.178	 -68.191	 6.6nM	±	0.7		
JWH-007	 -9.088	 -68.246	 9.5nM	±	4.5		
JWH-015	 -9.044	 -60.755	 383	nM	
JWH-122	 -8.895	 -64.202	 0.69	nM	±	0.5	
JWH-120	 -8.872	 -61.182	 1054	nM	
JWH-098	 -8.845	 -40.368	 4.5	nM	±	0.1	
JWH-081	 -8.84	 -63.183	 1.2	nM	±	0.03	
JWH-196	 -8.784	 -62.894	 151	nM	±	18	
JWH-148	 -8.756	 -64.212	 123	nM	
JWH-424	 -8.725	 -56.65	 20.9	nM	
JWH-073	 -8.706	 -61.424	 8.9	nM	
THC	
Molecule		 -8.686	 -63.34	 10	nM	
JWH-019	 -8.595	 -42.71	 9.8	nM	±	2	
JWH-210	 -8.536	 -54.984	 .46	nM	
JWH-116	 -8.5	 -54.951	 52	nM	±	5.0		
JWH-018	 -8.424	 -58.632	 9	nM	±	5.0	
JWH-185	 -8.074	 -68.61	 17	nM	
JWH-047	 -7.559	 -56.017	 59	nM	±	3.0	
JWH-398	 -7.452	 -61.263	 2.3	nM	
JWH-048	 -7.198	 -36.605	 10.7	nM	±	1.0	
Table	1:	Docking	Score	and	Glide	Emodel	score	of	each	JWH	ligand	and	THC		 		 Figure	4	and	Figure	24	show	the	two	ligands	and	their	interactions	with	the	CB1	model	that	had	the	best	docking	score	and	the	lowest	docking	score,	respectively.	JWH-149	was	shown	to	have	the	most	favorable	docking	score	of	-9.334,	and	JWH-	048	was	shown	to	have	the	least	favorable	docking	score	of	-7.198.	Figure	4	and	table	3	show	that	JWH-	149	has	Π-Π	stacking	interactions	with	residues	Tryptophan	279	(Trp	279),	Tryptophan	356	(Trp	356),	Phenylalanine	170	(Phe	170),	and	Phenylalanine	200	(Phe	200).	Most	ligands	that	resulted	in	high	
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docking	scores	showed	primarily	the	following	interactions	with	the	CB1	protein:	indole	substituent	interactions	with	Trp	279	and	to	a	lesser	degree	with	Phe	170	and	Trp	356;	naphthalene	interactions	with	Phe	170,	Trp	356,	and	Phe	200.			 		 Previous	studies	have	shown	that	residues	Serine	383	(Ser	383)	and	Lys	192	are	key	residues	in	forming	hydrogen	bonds	with	cannabinoid	ligands	possessing	OH	and	COOH	groups,	respectively.10	The	results	of	this	study	showed	that	only	two	docked	ligands	had	an	interaction	with	Lys	192.	A	hydrogen	bond	was	formed	between	Lys	192	and	the	keto-oxygen	portion	of	ligand	JWH-073,	and	Lys	192	had	a	pi-	cation	interaction	with	the	naphthalene	portion	of	ligand	JWH-048.	Interestingly,	JWH-073	had	a	docking	score	of	-8.706,	and	JWH-048	as	stated	previously	had	the	lowest	docking	score	of	-7.198.	Ser	383	also	formed	a	hydrogen	bond	with	the	keto-oxygen	of	ligands	JWH-098	and	JWH-424.	The	docking	scores	of	these	two	ligands	were	-8.845	and	-8.725,	respectively.	Analysis	of	the	interactions	between	the	CB1	model	and	the	ligands	also	showed	that	another	residue	formed	a	hydrogen	bond	in	the	same	way	with	the	keto-oxygen	of	the	ligands.	Similar	to	Lys	192	and	Ser	383,	Trp	279	formed	a	hydrogen	bond	with	the	keto-oxygen	of	ligands	JWH-015,	JWH-019,	JWH-018,	and	JWH-047.	The	docking	scores	of	each	of	these	ligands	were	-9.044,	-8.595,	-8.424,	and	-7.559,	respectively.				 The	strength	of	each	hydrogen	bond	formed	and	cation-pi	interaction	was	analyzed	through	measuring	the	distance	in	Angstroms.	The	hydrogen	bond	distance	between	Lys	192	and	JWH-073	was	measured	to	be	2.40Å	and	the	cation-pi	
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interaction	distance	between	Lys	192	and	JWH-	048	was	measured	to	be	3.77Å.	The	hydrogen	bond	distances	between	Trp	279	and	JWH-	015,	JWH-	019,	JWH-	018,	and	JWH-	047	were	measured	to	be	2.17	Å,	1.90	Å,	2.43	Å,	and	2.23	Å,	respectively.		The	hydrogen	bond	distance	between	Ser	383	and	JWH-	098	was	1.98	Å,	and	the	hydrogen	bond	distance	between	Ser	383	and	JWH-	424	was	2.04	Å.	The	shorter	distance	indicates	the	stronger	interaction.	The	distance	and	strength	of	each	hydrogen	bond	can	be	seen	in	table	2.			
Ligands		 Lys	192	 Trp	279	 Ser	383	
JWH-	073	 2.4	Å	 		 		
JWH-	015	 		 2.17	Å	 		
JWH-	019	 		 1.9	Å	 		
JWH-	018	 		 2.43	Å	 		
JWH-	047	 		 2.23	Å	 		
JWH-	098	 		 		 1.98	Å	
JWH-	424	 		 		 2.04	Å	
Table	2:	Distances	of	Hydrogen	Bonds	Formed	Between	Ligands	and	
Interacting	CB1	Residues					 Analysis	shows	that	the	hydrogen	bond	distances	between	both	Trp	279	and	Ser	383	and	their	respective	interacting	ligands	were	shorter	and	therefore	stronger	than	the	hydrogen	bond	distance	between	Lys	192	and	its	respective	interacting	ligand.	This	indicates	that	Lys	192	does	not	interact	as	significantly	with	the	JWH	ligands	as	other	residues	such	as	Trp	279	and	Ser	383.	More	research	on	these	residues	could	indicate	their	significance	in	forming	hydrogen	bonds	with	new	and	undiscovered	cannabinoid	ligands.			
		 18	
	 Previous	studies	have	indicated	that	residues	Phe	170,	Phe	200,	Phe	208,	Tyr	215,	Phe	289,	Tyr	292,	Tyr	296,	Trp	356,	and	Phe	379	are	essential	CB1	residues	for	aromatic	stacking.	Previous	studies	have	also	shown	that	residues	Phe	170	and	Trp	279	are	present	in	the	deep	binding	pocket	of	the	CB1	receptor.	This	binding	pocket	is	essential	for	effective	ligand	binding.10	The	results	of	this	study	show	that	Trp	279,	Trp	356,	Phe	200,	and	Phe	170	are	key	residues	in	JWH	and	CB1	binding.	Trp	279	interacted	with	eighteen	of	the	twenty-	one	ligands	and	the	THC	molecule.	This	is	the	most	interactions	of	all	of	the	residues.	Trp	279	was	also	chosen	as	the	central	point	for	docking,	so	it	makes	sense	that	it	had	the	most	interactions.	Trp	356	interacted	with	fifteen	of	the	ligands,	and	Phe	200	interacted	with	ten	of	the	ligands,	and	Phe	170	interacted	with	eleven	ligands.	Interactions	with	residues	Phe	177	and	Phe	174	also	occurred,	but	only	with	the	lowest	scoring	ligand,	JWH-048.	THC	and	the	JWH	ligands	used	in	this	study	are	listed	in	Table	3	along	with	the	CB1	residues	with	which	they	interact.										
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	 CB1	Receptor	Residues		
	 	 	Ligands		 Trp	279	 Trp	356	 Phe	170	 Phe	200	 Phe	177	 Phe	174	 Lys	192	 Ser	383	
THC	
Molecule	 ✓    	 	 	 	
JWH-149	 ✓ ✓ ✓ ✓ 		 		 		 		
JWH-184	 ✓ ✓ ✓ 		 		 		 		 		
JWH-073	 ✓ 		 		 		 		 		 ✓ 		
JWH-164	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-007	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-015	 ✓ ✓ ✓ 		 		 		 		 		
JWH-122	 ✓ ✓ ✓ 		 		 		 		 		
JWH-120	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-098	 ✓ ✓ 		 ✓ 		 		 		 ✓ 
JWH-081	 ✓ ✓ ✓ ✓ 		 		 		 		
JWH-196	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-148	 ✓ 		 		 		 		 		 		 		
JWH-424	 ✓ ✓ ✓ ✓ 		 		 		 ✓ 
JWH-019	 ✓ 		 		 		 		 		 		 		
JWH-210	 		 ✓ ✓ 		 		 		 		 		
JWH-116	 		 ✓ ✓ ✓ 		 		 		 		
JWH-018	 ✓ ✓ ✓ 		 		 		 		 		
JWH-185	 ✓ ✓ ✓ 		 		 		 		 		
JWH-047	 ✓ 		 ✓ ✓ 		 		 		 		
JWH-398	 		 		 		 		 		 		 		 		
JWH-048	 ✓ 		 		 		 ✓ ✓ ✓ 		
	  	 	 	    	
Table	3:	JWH	Ligands	and	THC	and	Their	Interacting	CB1	Residues		 				
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	 The	interacting	residues	showed	Π-Π	or	cation-pi,	only	Lys	192	and	JWH-048,	interactions	with	either	the	indole	substructure	of	the	ligand	or	the	naphthalene	substructure	of	the	ligand.	The	shortest	carbon-carbon	interaction	distance	between	the	CB1	residues	and	the	ligands	was	measured.	These	distances	can	be	seen	in	Table	4.	The	THC	molecule	only	showed	an	interaction	with	Trp	279.	The	benzene	ring	containing	an	OH	substituent	group	exhibited	pi-pi	stacking	with	a	distance	of	3.92Å	with	Trp	279.																
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Ligands	 Trp	279	
and	
indole	
Phe	170	
and	
indole		
Trp	356	
and	
indole		
Phe	170	and	
nap.	
Trp	356	and	
nap.	
Phe	200	
and	nap.	
Trp	279	
and	nap.	
Phe	174	
and	nap.	
Phe	177	and	
nap.	
JWH-	149	 3.53Å	 	 	 3.32Å	 3.51Å	 4.09Å	 	 	 	JWH-	184	 	 3.62Å	 3.59Å	 	 	 	 3.57Å	 	 	JWH-	073	 3.30Å	 	 	 	 	 	 	 	 	JWH-	164	 3.59Å	 	 	 	 3.84Å	 3.43Å	 	 	 	JWH-	007	 3.59Å	 	 	 	 3.50Å	 3.41Å	 	 	 	JWH-	015	 3.62Å	 	 	 3.34Å	 3.53Å	 	 	 	 	JWH-	122	 3.45Å	 	 	 3.29Å	 3.47Å	 	 	 	 	JWH-	120	 3.58Å	 	 	 	 3.65Å	 3.51Å	 	 	 	JWH-	098	 3.61Å	 	 	 	 3.53Å	 3.35Å	 	 	 	JWH-	081	 3.44Å	 	 	 3.26Å	 3.32Å	 3.59Å	 	 	 	JWH-	196	 3.60Å	 	 	 	 3.79Å	 3.46Å	 	 	 	JWH-	148	 	 	 	 	 	 	 3.53Å	 	 	JWH-	424	 3.78Å	 	 	 3.55Å	 3.66Å	 3.32Å	 	 	 	JWH-	019	 3.50Å	 	 	 	 	 	 	 	 	JWH-	210	 	 	 	 3.21Å	 3.47Å	 	 	 	 	JWH-	116	 	 	 	 3.27Å	 3.80Å	 3.39Å	 	 	 	JWH-	018	 3.45Å	 	 	 3.43Å	 3.67Å	 	 	 	 	JWH-	185	 	 3.41Å	 3.65Å	 	 	 	 3.58Å	 	 	JWH-	047	 	 	 	 3.28Å	 	 3.45Å	 	 	 	JWH-	398	 	 	 	 	 	 	 	 	 	JWH-	048	 3.67Å	 	 	 	 	 	 	 4.53Å	 3.41Å	
Table	4:	The	Interactions	Between	the	Indole	or	Naphthalene	Substructures	of	each	
Ligand	and	CB1	residue	*And	indole	denotes	a	pi	pi	stacking	(Π-Π)	interaction	between	the	CB1	substituent	and	the	indole	portion	of	the	ligand.	**And	nap.	denotes	a	pi	pi	stacking	(Π-Π)	interaction	between	the	CB1	substituent	and	the	naphthalene	portion	of	the	ligand	
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	 As	seen	in	table	4,	most	distances	were	in	the	3	to	4Å	range	with	only	2	interaction	distances	greater	than	4Å.	The	strongest	interaction,	judged	by	the	shortest	distance,	occurred	between	Phe	170	and	the	naphthalene	substructure	of	JWH-210.	This	result	seems	inconsistent	with	the	docking	scores	since	JWH-	210	produced	a	docking	score	on	the	bottom	half	of	the	docking	score	table	with	a	score	of	-8.536.	Though	JWH-210	produced	a	docking	score	in	the	bottom	half	of	the	docking	score	range,	JWH-210	possesses	the	highest	experimental	binding	affinity	(lowest	Ki	value=	0.46nM)	at	CB1	of	all	the	ligands	tested	in	this	study.	This	high	binding	affinity	for	CB1	should	be	investigated	further	to	explain	why	JWH-210	and	Phe	170	have	the	strongest	interaction.	The	weakest	interaction,	or	longest	distance,	was	seen	between	Phe	174	and	the	naphthalene	portion	of	JWH-048.	This	finding	is	consistent	with	the	resulting	docking	scores	as	JWH-048	produced	the	lowest	docking	score.	JWH-048	was	also	the	only	ligand	to	interact	with	Phe	174.	Because	Phe	170	formed	the	strongest	interaction	and	interacted	with	eleven	ligands,	further	studies	should	be	done	in	order	to	determine	if	Phe	170	is	also	a	key	residue	in	all	cannabinoid	ligand	binding	with	CB1.				 Because	THC	is	the	main	psychoactive	component	of	marijuana,	it	could	be	assumed	that	THC	would	produce	the	strongest	interaction	with	CB1,	interact	with	the	most	CB1	residues,	and	have	the	highest	docking	score.	As	seen	in	table	1,	THC	produced	a	docking	score	of	-8.686	with	this	active-state	CB1	model.	This	docking	score	is	in	the	middle	to	bottom	half	range	of	the	resulting	JWH	ligand	docking	scores.	The	best	pose	of	the	THC	molecule	selected	and	analyzed	also	only	
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interacted	with	Trp	279	through	Π-Π	stacking	at	a	distance	of	3.92Å.	An	explanation	for	why	THC	does	not	possess	the	best	docking	score	could	be	its	binding	affinity	for	CB1.	Though	THC	possesses	a	binding	affinity	of	10nM	for	CB1,	eleven	of	the	twenty-one	ligands	studied	possess	a	higher	binding	affinity,	lower	Ki	value,	for	CB1	than	THC.	These	higher	binding	affinities	cause	the	ligands	to	bind	to	CB1	more	strongly	than	THC	and	potentially	cause	more	harmful	effects.1	The	interactions	between	the	CB1	model	and	each	of	the	twenty-one	ligands	and	THC	are	shown	in	2D	and	3D	interaction	diagrams	in	figures	4-	25.									
		 Figure	4:	JWH-	149	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams			
	
Phe	170	 Trp	279	
Phe	200	
Trp	356	
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		 Figure	5:	JWH-	184	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams				
				 	Figure	6:	JWH-	073	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.	H-bond	is	shown	as	yellow-colored	dashes.		
Phe	170	 Trp	279	
Trp	356	
Lys	192	 Trp	279	
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	 								 					 		 			Figure	7:	JWH-	164	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams			 								 						 		 					Figure	8:	JWH-	007	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams		
Trp	279	
Trp	356	
Phe	200	
Trp	279	
Trp	356	
Phe	200	
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																																																																													 Figure	9:	JWH-	015	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.	H-bond	is	shown	as	yellow-	colored	dashes																																																																												 Figure	10:	JWH-	122	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams	
Trp	279	
Phe	170	
Trp	356	
Trp	279	
Phe	170	
Trp	356	
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																																																																								Figure	11:	JWH-	120	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams								
																																																																																 Figure	12:	JWH-	098	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams		
Trp	279	
Trp	356	 Phe	200	
Trp	279	
Trp	356	
Phe	200	
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		 Figure	13:	JWH-	081	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams																																																																																															 	Figure	14:	JWH-	196	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams	
Trp	279	
Phe	200	
Trp	356	
Phe	170	
Trp	279	
Trp	356	
Phe	200	
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																																																																																		 Figure	15:	JWH-	148	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams				
																																																																																										 	Figure	16:	JWH-	424	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams	
Trp	279	
Trp	279	
Phe	170	
Trp	356	
Phe	200	
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																																																																																	 Figure	17:	JWH-	019	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.	H-	bond	is	shown	as	yellow-	colored	dashes.																																																																																															 	Figure	18:	JWH-	210	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams	
Trp	279	
Trp	356	
Phe	170	
		 31	
																																																																																																								 Figure	19:	JWH-	116	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams				
																																																																																											 	Figure	20:	JWH-	018	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.	H-	bond	is	shown	as	yellow-	colored	dashes.	
Trp	356	
Phe	200	
Phe	170	
Trp	279	 Phe	170	
Trp	356	
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																																																																																							 Figure	21:	JWH-	185	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams																																																																																			 Figure	22:	JWH-	047	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.	H-	bond	is	shown	as	yellow-	colored	dashes.		
Trp	279	
Trp	356	
Phe	170	
Trp	279	 Phe	170	
Phe	200	
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																																																																																															 	Figure	23:	JWH-	398	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.						
																																																																																																																																																																																			 Figure	24:	JWH-	048	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams	
Phe	174	Trp	279	
Phe	177	
Lys	192	
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																																																																																																	 Figure	25:	THC	and	CB1	2D	and	3D	Ligand	Interaction	Diagrams.			
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CONCLUSION	
		 This	study	revealed	that	Trp	279,	Trp	356,	Phe	200,	and	Phe	170	are	key	residues	in	the	interaction	between	CB1	and	JWH	ligands.	It	appears	that	Trp	279	could	also	be	a	key	residue	in	forming	hydrogen	bonds	with	other	cannabinoid	classes.		Further	research	on	interactions	between	JWH	metabolites	and	other	classes	of	cannabinoids	with	this	CB1	model	could	reveal	additional	important	CB1	residues	involved	in	the	binding	of	new	and	uncharacterized	cannabinoids.	More	studies	should	be	performed	on	the	ligand-receptor	interaction	to	ultimately	create	a	new	mass	spec	database	for	the	detection	and	prediction	of	a	variety	of	illicit	synthetic	cannabinoids.		
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